Bromo-DragonFLY: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
Tags: mobile edit mobile web edit
Line 1: Line 1:
'''Bromo-DragonFLY''' is a [[psychoactive drug]] that is related to the [[phenethylamine]] family. It is known for its complex and long-lasting effects, which can last for up to several days. Bromo-DragonFLY is considered a [[research chemical]], meaning it is not approved for medical use and is often used in scientific research.
{{DISPLAYTITLE:Bromo-DragonFLY}}


== History ==
==Overview==
Bromo-DragonFLY was first synthesized in 1998 by the team of [[David E. Nichols]] at [[Purdue University]]. It was originally developed as a tool for [[neuroscience]] research, specifically for studying the [[5-HT2A receptor]]. The drug's effects were first documented in the scientific literature in 2001.
[[File:Packet_of_4BDF_powder.jpg|thumb|right|Packet of Bromo-DragonFLY powder]]
'''Bromo-DragonFLY''' is a potent hallucinogenic drug belonging to the [[phenethylamine]] class. It is known for its long-lasting effects and high potency, which can lead to severe [[vasoconstriction]] and other dangerous side effects. Bromo-DragonFLY is structurally related to the [[2C family]] of psychedelic phenethylamines and is often compared to [[LSD]] due to its powerful psychoactive properties.


== Pharmacology ==
==Chemical Structure and Properties==
Bromo-DragonFLY is a potent [[agonist]] for the 5-HT2A receptor, which is involved in the regulation of mood, anxiety, and perception. It also has affinity for other [[serotonin receptor]]s, including 5-HT1A, 5-HT1B, and 5-HT1D. The drug's effects are thought to be primarily due to its action on these receptors.
Bromo-DragonFLY is a derivative of the [[benzodifuran]] class, characterized by its complex chemical structure that includes a bromine atom. The full chemical name is 1-(8-bromobenzo[1,2-b:4,5-b']difuran-4-yl)-2-aminopropane. This structure contributes to its high affinity for the [[serotonin receptor]]s, particularly the 5-HT2A receptor, which is primarily responsible for its hallucinogenic effects.


== Effects ==
==Pharmacology==
The effects of Bromo-DragonFLY are highly variable and can last for up to several days. They can include [[hallucination]]s, altered perception of time, and intense emotional experiences. Some users have also reported physical effects such as increased heart rate, high blood pressure, and vasoconstriction.
Bromo-DragonFLY acts as a potent agonist at the 5-HT2A receptor, similar to other hallucinogens like LSD and [[psilocybin]]. Its effects can last significantly longer than those of other psychedelics, with reports of experiences lasting up to 36 hours or more. This extended duration is due to its slow metabolism and high receptor affinity.


== Legal status ==
==Effects==
The legal status of Bromo-DragonFLY varies by country. In some countries, it is classified as a [[controlled substance]], while in others it is legal to possess and use.
The effects of Bromo-DragonFLY can vary widely depending on the dose and individual sensitivity. Common effects include intense visual and auditory hallucinations, altered perception of time, and profound changes in thought processes. However, due to its potency, it can also cause severe adverse effects such as [[vasoconstriction]], which can lead to tissue damage and [[necrosis]] if not treated promptly.


== See also ==
==Risks and Safety==
Bromo-DragonFLY is associated with a high risk of overdose and severe side effects. The narrow therapeutic index means that the difference between a recreational dose and a potentially lethal dose is small. Users have reported severe [[vasoconstriction]], leading to [[gangrene]] and [[amputation]] in extreme cases. Due to these risks, Bromo-DragonFLY is considered highly dangerous and is classified as a controlled substance in many countries.
 
==Legal Status==
Bromo-DragonFLY is illegal in several countries due to its potential for abuse and severe health risks. It is classified as a Schedule I substance in the United States, meaning it is considered to have a high potential for abuse and no accepted medical use.
 
==Related pages==
* [[Phenethylamine]]
* [[Phenethylamine]]
* [[LSD]]
* [[Serotonin receptor]]
* [[Psychedelic drug]]
* [[Psychedelic drug]]
* [[Research chemical]]
[[Category:Psychoactive drugs]]
[[Category:Research chemicals]]
[[Category:Phenethylamines]]


{{stub}}
[[Category:Psychedelic phenethylamines]]
[[Category:Serotonin receptor agonists]]
[[Category:Controlled substances]]

Revision as of 11:10, 15 February 2025


Overview

Packet of Bromo-DragonFLY powder

Bromo-DragonFLY is a potent hallucinogenic drug belonging to the phenethylamine class. It is known for its long-lasting effects and high potency, which can lead to severe vasoconstriction and other dangerous side effects. Bromo-DragonFLY is structurally related to the 2C family of psychedelic phenethylamines and is often compared to LSD due to its powerful psychoactive properties.

Chemical Structure and Properties

Bromo-DragonFLY is a derivative of the benzodifuran class, characterized by its complex chemical structure that includes a bromine atom. The full chemical name is 1-(8-bromobenzo[1,2-b:4,5-b']difuran-4-yl)-2-aminopropane. This structure contributes to its high affinity for the serotonin receptors, particularly the 5-HT2A receptor, which is primarily responsible for its hallucinogenic effects.

Pharmacology

Bromo-DragonFLY acts as a potent agonist at the 5-HT2A receptor, similar to other hallucinogens like LSD and psilocybin. Its effects can last significantly longer than those of other psychedelics, with reports of experiences lasting up to 36 hours or more. This extended duration is due to its slow metabolism and high receptor affinity.

Effects

The effects of Bromo-DragonFLY can vary widely depending on the dose and individual sensitivity. Common effects include intense visual and auditory hallucinations, altered perception of time, and profound changes in thought processes. However, due to its potency, it can also cause severe adverse effects such as vasoconstriction, which can lead to tissue damage and necrosis if not treated promptly.

Risks and Safety

Bromo-DragonFLY is associated with a high risk of overdose and severe side effects. The narrow therapeutic index means that the difference between a recreational dose and a potentially lethal dose is small. Users have reported severe vasoconstriction, leading to gangrene and amputation in extreme cases. Due to these risks, Bromo-DragonFLY is considered highly dangerous and is classified as a controlled substance in many countries.

Legal Status

Bromo-DragonFLY is illegal in several countries due to its potential for abuse and severe health risks. It is classified as a Schedule I substance in the United States, meaning it is considered to have a high potential for abuse and no accepted medical use.

Related pages